ADOC.PA
Price:
$10.28
Market Cap:
$156.63M
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed to optimize the performance of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucag...[Read more]
Industry
Biotechnology
IPO Date
2012-02-20
Stock Exchange
EURONEXT
Ticker
ADOC.PA
According to Adocia SA’s latest financial reports and current stock price. The company's current ROE is 360.25%. This represents a change of 241.11% compared to the average of 105.61% of the last 4 quarters.
The mean historical ROE of Adocia SA over the last ten years is -71.02%. The current 360.25% ROE has changed -607.27% with respect to the historical average. Over the past ten years (40 quarters), ADOC.PA's ROE was at its highest in in the June 2021 quarter at 255.21%. The ROE was at its lowest in in the September 2014 quarter at -302.79%.
Average
-71.02%
Median
-0.92%
Minimum
-826.95%
Maximum
306.07%
Discovering the peaks and valleys of Adocia SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.58%
Maximum Annual ROE = 306.07%
Minimum Annual Increase = -499.45%
Minimum Annual ROE = -826.95%
Year | ROE | Change |
---|---|---|
2023 | 306.07% | 475.20% |
2022 | 53.21% | -72.06% |
2021 | 190.43% | -151.71% |
2020 | -368.23% | 455.03% |
2019 | -66.34% | -499.45% |
2018 | 16.61% | -171.59% |
2017 | -23.20% | 25.71% |
2016 | -18.46% | -169.18% |
2015 | 26.68% | -103.23% |
2014 | -826.95% | 3.58% |
The current ROE of Adocia SA (ADOC.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
183.24%
5-year avg
23.03%
10-year avg
-71.02%
Adocia SA’s ROE is greater than Genfit S.A. (1.77%), greater than Innate Pharma S.A. (-84.39%), less than Nanobiotix S.A. (283.43%), greater than Cellectis S.A. (-79.97%), greater than ERYTECH Pharma S.A. (-84.88%),
Company | ROE | Market cap |
---|---|---|
1.77% | $272.45M | |
-84.39% | $135.35M | |
283.43% | $187.03M | |
-79.97% | $124.43M | |
-84.88% | $48.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adocia SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adocia SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Adocia SA's ROE?
How is the ROE calculated for Adocia SA (ADOC.PA)?
What is the highest ROE for Adocia SA (ADOC.PA)?
What is the 3-year average ROE for Adocia SA (ADOC.PA)?
What is the 5-year average ROE for Adocia SA (ADOC.PA)?
How does the current ROE for Adocia SA (ADOC.PA) compare to its historical average?